
Mesa Laboratories Inc
NASDAQ:MLAB

Mesa Laboratories Inc
Free Cash Flow
Mesa Laboratories Inc
Free Cash Flow Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | Free Cash Flow | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
![]() |
Mesa Laboratories Inc
NASDAQ:MLAB
|
Free Cash Flow
$43m
|
CAGR 3-Years
4%
|
CAGR 5-Years
9%
|
CAGR 10-Years
21%
|
|
![]() |
Becton Dickinson and Co
NYSE:BDX
|
Free Cash Flow
$2.9B
|
CAGR 3-Years
3%
|
CAGR 5-Years
1%
|
CAGR 10-Years
11%
|
|
![]() |
Boston Scientific Corp
NYSE:BSX
|
Free Cash Flow
$2.2B
|
CAGR 3-Years
18%
|
CAGR 5-Years
12%
|
CAGR 10-Years
8%
|
|
![]() |
Stryker Corp
NYSE:SYK
|
Free Cash Flow
$3.5B
|
CAGR 3-Years
8%
|
CAGR 5-Years
18%
|
CAGR 10-Years
8%
|
|
![]() |
Abbott Laboratories
NYSE:ABT
|
Free Cash Flow
$6.4B
|
CAGR 3-Years
-10%
|
CAGR 5-Years
7%
|
CAGR 10-Years
9%
|
|
![]() |
Intuitive Surgical Inc
NASDAQ:ISRG
|
Free Cash Flow
$586m
|
CAGR 3-Years
-30%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
0%
|
Mesa Laboratories Inc
Glance View
Mesa Laboratories, Inc. engages in the design, manufacture, and market of instruments and disposable products utilized in healthcare, pharmaceutical, food and beverage, medical device, and petrochemical industries. The company is headquartered in Lakewood, Colorado and currently employs 506 full-time employees. The firm operates through four segments, Sterilization and Disinfection Control, Biopharmaceutical Development, Instruments, and Continuous Monitoring. The Sterilization and Disinfection Control segment manufactures and sells biological, cleaning, and chemical indicators which are used to assess the effectiveness of sterilization and disinfection processes in the hospital, medical device, and pharmaceutical industries. The Biopharmaceutical Development segment develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. The Instruments segment designs, manufactures, and markets quality control hardware and disposable products. The Continuous Monitoring segment develops, and markets systems which are used to monitor various environmental parameters such as temperature, humidity, and differential pressure.

See Also
What is Mesa Laboratories Inc's Free Cash Flow?
Free Cash Flow
43m
USD
Based on the financial report for Dec 31, 2024, Mesa Laboratories Inc's Free Cash Flow amounts to 43m USD.
What is Mesa Laboratories Inc's Free Cash Flow growth rate?
Free Cash Flow CAGR 10Y
21%
Over the last year, the Free Cash Flow growth was 6%. The average annual Free Cash Flow growth rates for Mesa Laboratories Inc have been 4% over the past three years , 9% over the past five years , and 21% over the past ten years .